Cigarette smoking ameliorates ulcerative colitis (UC) and aggravates Crohn's disease (CD). Cigarette smoke suppresses infl ammation-induced apoptosis in intestinal epithelial cells (DLD-1) and T-lymphocytes (Jurkat), which may explain the opposite eff ects in UC and CD. Here, we performed transcriptome profi ling of cigarette smoke extract (CSE)-exposed DLD-1 and Jurkat cells and related this to UC susceptibility genes with protective functions in the intestinal epithelium.
INTRODUCTION
Cigarette smoking is a prominent risk factor for multiple diseases, including cardiac and respiratory diseases, infections and malignancies, increasing morbidity and mortality worldwide. On the other hand, there is accumulating evidence that cigarette smoke also may have benefi cial eff ects in neurodegenerative 1 nd infl ammatory disorders, with ulcerative colitis (UC) as a prime example.
UC is an infl ammatory bowel disease (IBD) in which the infl ammation is limited to superfi cial layers of the intestinal mucosa, typically ascending in a continuous manner from the rectum and may involve the whole colon (pancolitis). UC is a complex disorder caused by a combination of genetic and environmental (e.g. smoking and diet) factors, but the exact etiology is unknown. Rapid increases in disease incidence over the past 50-60 years and diff erences in geographic distribution 2 , support the importance of environmental factors in modifying the risk for developing UC.
Cigarette smoking is the best established environmental factor in IBD and a peculiar one, since it has opposite eff ects on UC and Crohn's disease (CD), the two main types of IBD. UC predominantly aff ects non-smokers and former smokers 3-6 suggesting a protective eff ect of smoking in disease development. Moreover, smoking dosedependently ameliorates the disease course and severity, exemplifi ed by a reduced chance of pancolitis, less steroids and immunosuppressives use and reduced hospitalizations and colectomy rates in UC patients who smoke [7] [8] [9] [10] .
Although the positive eff ect of cigarette smoking on UC is already known for many years, the precise cellular and/or molecular mechanisms involved are still poorly understood. The healthy intestinal tract contains several barriers to protect the body against pathogenic invasion. A fi ne-tuned balance between epithelial loss and cell proliferation is required to maintain this barrier and limit infl ammation. Regulated cell death through apoptosis is a key mechanism to maintain the integrity of the intestinal epithelium 11, 12 . UC is characterized by excessive apoptotic cell loss in the intestinal epithelium 12, 13 , exposing the underlying tissue to pathogens that elicit an infl ammatory response. and many of these substances have been shown to cause cellular injury through the production of reactive oxygen species, leading to oxidative stress and eventually to cell death 14 . However, cigarette smoke may also induce the expression of cytoprotective stress proteins, including heme oxygenase 1 (HO-1) and heat shock proteins (HSPs) [15] [16] [17] [18] [19] . In the present study, we performed a whole genome transcriptome analysis on DLD-1 and Jurkat cells exposed to cigarette smoke extract in order to identify genes and/or cell pathways that underlie its protective eff ect against apoptosis. Genes of which expression was most prominently modulated by CSE were compared to those residing in UC susceptibility loci and expression in the human colonic epithelium was studied by immunohistochemistry. Finally, we focused on potential anti-apoptotic actions that may explain the positive eff ect of cigarette smoke on colitis in UC.
MATERIALS AND METHODS

HUMAN TISSUE SPECIMENS
Colonic biopsies were obtained from smoking and non-smoking healthy patients undergoing colonoscopy after written informed consent at the University Medical Center Groningen, The Netherlands. Characteristics of the participants are described in Table 1 . Smokers (median 17 cigarettes/day and 30 years smoking history) smoked one Kentucky 3R4F research cigarette 30 minutes before colonoscopy. Biopsies were taken from the ascending colon. Specimens for Q-PCR were immediately snapfrozen in liquid nitrogen and stored at -80°C until further processing. Specimens for Biosystems, NY, USA) as described 26 . Primers and probes used in this study are listed in Supplementary Table S1 . Subsequently, cycle numbers at which the sample fl uorescence signal increases above a fi xed threshold level (CT value) were normalized to the endogenous control (β-actin or 18S) and correlated inversely with initial mRNA levels. 
TOTAL PROTEIN EXTRACTION AND WESTERN BLOTTING
IMMUNOHISTOCHEMISTRY
Immunohistochemistry was performed as previously described 20 . For HSPA6 detection, antigen retrieval was performed in 10 mM citrate buff er, pH 6.0. Staining of endogenous HSPA6 was carried out using rabbit polyclonal α-HSPA6 antibody We next analyzed the CSE-induced expression of selected HSPs in more detail by Q-PCR. Messenger RNA levels of HSPA6, HSPA1B, HSPH1 and DNAJB1 were both time-and dose-dependently induced by CSE. Again, induction levels were most prominent for HSPA6, which increased >300-fold in both DLD-1 and Jurkat cells after 6 hours exposure. (Figure 2A and B) . CYP1A1 was also sharply induced (>100fold) in DLD-1 cells exposed for 2 hours to low concentrations (5%) of CSE. Higher concentrations and later time points revealed a concentration and time-dependent decrease in CYP1A1 expression, though at all conditions it was enhanced compared to untreated control DLD-1 cells. Remarkably, CSE did not enhance CYP1A1 in Jurkat cells. In fact, a dose-dependent decrease for this gene was observed, which is in line with the fact that CYP1A1 was not identifi ed as CSE-regulated gene in Jurkat cells in the microarray analysis. Taken together, the results show that induction of HSPs, and in particular HSPA6 and HSPA1B, is a conserved response in intestinal epithelial cells
and T-lymphocytes when exposed to cigarette smoke.
HSPA6 RESIDES IN A UC SUSCEPTIBILITY LOCUS
Next, we compared the diff erentially expressed genes of our microarray data set to genes that reside in UC susceptibility loci. Six potential UC-associated genes were present in the 372 CSE-regulated genes in the DLD-1 cells, while 14 potential UCassociated genes were present in the 2,396 CSE-regulated genes in Jurkat cells (Table 4A and B) . HSPA6, HSPA1B and SNAPC4 were detected for both cell types.
Interestingly, a signifi cant cis-eQTL eff ect (3.38E-03) for HSPA6 has been described for the UC-associated SNP locus rs1801274. HSPA6 expression is decreased in individuals homozygous for the risk variant 25 .
HSPA6 IS STRONGLY EXPRESSED IN EPITHELIAL CELLS OF THE COLON
HSPA6 is known as a "strictly inducible gene", meaning that it is not expressed under normal/healthy conditions [28] [29] [30] [31] . As the intestinal epithelium can be considered to face continuous "environmental" stress, we analyzed whether HSPA6 expression can be detected in the human colon. Q-PCR analyses revealed that HSPA6 mRNA was readily detected in the colon biopsies from healthy volunteers ( Figure 3A ).
HSPA6 mRNA levels were highly variable in volunteers who smoke, but as a group did not show enhanced levels compared to non-smokers or ex-smokers (unknown HSPA6 genotype). Immunohistochemical staining revealed that HSPA6 expression is prominently present in colon epithelial cells at the mucosal surface ( Figure 3B ). Western blot analysis revealed a strong, but highly transient response of HSPA6 to CSE treatment ( Figure 4A ). HSPA6 was absent in unstressed cells, but became detectable after 4 hours of 20% CSE treatment. Under these conditions, HSPA6 protein levels peaked at 6 hours, after which it rapidly disappeared. Increasing the dose of CSE to 30% led to a delayed induction of HSPA6, now peaking at 8 hours after which it also rapidly declined ( Figure 4A ). Immunofl uorescence microscopy showed that HSPA6
primarily localizes to the nucleus as well as to the cytosol in CSE-exposed DLD-1 cells ( Figure 4B ). Eff ective concentrations of CSE used do not reduce cell viability and/or metabolic activity of the cells (Figure 2A and B) , as we also reported before (Chapter 
Cigarette smoke suppresses infl ammation-induced apoptosis (Chapter 3; Regeling
A et al., submitted). HSPA family members have been shown to interact and stabilize anti-apoptotic Bcl-2 proteins 32, 33 , but this has not yet been established for HSPA6.
In fact, HSPA6 is a non-typical HSP70 protein, as it does not provide protection against heat-induced cell death and lacks refolding activity of model substrates, like luciferase and polyQ aggregates 34 . As observed for HSPA6, CSE dose-dependently enhanced protein levels of anti-apoptotic Bcl-XL ( Figure 5A ), while it did not aff ect
Bcl-XL mRNA levels (data from micro array analysis). This suggests that CSE aff ects
Bcl-XL protein levels through posttranscriptional mechanisms. Using HSPA6-specifi c antibodies HSPA6 was eff ectively precipitated total protein extracts of control and CSE-exposed DLD-1 cells. The precipitates of CSE-exposed cells contained signifi cant amounts of Bcl-XL ( Figure 5B ; left panel). Both proteins were absent from immunoprecipitates of total extracts from control DLD-1 cells. In a complementary approach, we precipitated Bcl-XL from total extracts of control and CSE-exposed DLD-1 cells ( Figure 5B ; right panel). As expected, signifi cant amounts of HSPA6 coimmune precipitated with Bcl-XL in total protein extracts of CSE-exposed DLD-1 cells, but not in control cells. Collectively, these data show that CSE-induced expression of HSPA6 stabilizes Bcl-XL, which provides protection against apoptosis in cigarette smoke exposed intestinal epithelial cells. HSPA6 is a heat shock protein of 70 kDa, belonging to the HSPA subfamily containing 12 additional homologs in human. Typically, HSPAs serve as molecular chaperones and maintain protein homeostasis (e.g. assisting folding of newlysynthesized proteins and suppressing protein aggregation), in particular in response to environmental stress conditions, thereby providing cytoprotection [35] [36] [37] . HSPA6 is described as strictly stress-inducible 30, 34, 35 and is thought to be involved in cytoprotection 30 In order to identify potential mechanisms that underlie the benefi cial eff ects of smoke in UC, we next compared the CSE-induced genes to genes that reside in UC susceptibility loci. Three CSE-induced genes are located in UC-susceptibility loci, 2 of which fall into the HSP70 family of proteins, HSPA1B and HSPA6. HSPA6 resides in locus rs1801274 that also contains genes encoding immunoglobulin receptor FCGR2A and FCGR2B. The rs1801274 is supposed to be a nonsynonymous SNP (H131R) of FCGR2A that aff ects receptor-binding affi nity for IgG 41 and has been reported to be associated with other autoimmune diseases, including stemic lupus erythematosus (SLE) 42, 43 , Guillain-Barré syndrome 41, 44 , multiple sclerosis 41 and type 1 diabetes 45, 46 . However, this does not exclude the possibility that an additional gene in this locus, e.g. HSPA6, may also increase the risk for UC. In a similar way, SNPs in IL-2
and IL-21 were found to independently increase the risk for UC, while originally they were found in one UC susceptibility locus 47 . Importantly, the rs1801274 is associated with decreased expression of HSPA6, which may impair its cytoprotective role in the colonic epithelium 25, 48 .
Several studies have evaluated the expression of HSPs (e.g. HSP27 and HSP70) in the gastrointestinal tract. They appear to be most dominantly expressed in regions facing the highest stress conditions, e.g. the acidic environment of the stomach and colon [49] [50] [51] [52] . In the colon, HSP27 and HSP70 are primarily detected in the surface epithelium 49, 53 . This corresponds well to our fi ndings that HSPA6 is prominently expressed in the surface epithelium of the colon of healthy volunteers. Since HSPA6 expression is considered to be strictly stress-controlled, this implies that colonic epithelium is exposed to signifi cant cellular stress even under healthy conditions.
Intestinal expression of several HSPs (e.g. HSP10/32/60/70/72) was reported to be enhanced in IBD patients [54] [55] [56] [57] , as well as in animal models of IBD [58] [59] [60] . Moreover, HSP10/70/90 expression is reduced upon successful therapy 57 . These fi ndings have been interpreted as that HSPs may promote the development of IBD. However, it is more likely that the enhanced HSP expression is due to the (pro-) infl ammatory conditions in the colon of IBD patients and may actually suppress excessive colonic tissue damage. This is supported by the observations that compromised expression of HSP70 aggravates DSS-induced colitis 50, 61, 62 . Moreover, overexpression of HSP70 protected against DSS-induced colitis in HSP70 transgenic mice and was associated with suppression of pro-infl ammatory cytokines, e.g. IL-6, VCAM and IL-1β 50, 62, 63 . Such direct proof of the protective role HSPs in colitis is further supported by earlier studies that hyperthermia, the classical inducer of HSPs, was shown to protect rats against colitis induced by, amongst others, TNBS and acetic acid 64 A direct role of HSPA6 in protection against colitis remains to be determined. A major disadvantage is that HSPA6 is only present in large mammals, e.g. not in mice and rats, so indications need to come from (genetic) studies on humans and cellmolecular studies in human cell (line)s. We show that CSE-induced HSPA6 interacts with Bcl-XL and is associated with transcription-independent enhanced levels of this anti-apoptotic protein. Earlier, we described the anti-apoptotic eff ect of cigarette smoke in detail and the HSPA6-enhanced Bcl-XL levels will contribute to this eff ect, thereby alleviating damage to the colonic epithelium in UC patients. Interestingly, HSP70 and Bcl-XL 32 have been reported to physically interact. Thus, both HSPs may act together in the anti-apoptotic eff ect and protect against colitis.
The short-lived expression of HSPA6 and timing of peak expression induced by cigarette smoke is highly dose-dependent. This maybe the reason why we did not detect signifi cantly enhanced HSPA6 levels in colonic biopsies from individuals who smoke. Still, smoking leads to enhanced levels of other genes in the human colon, e.g. CYP1A1 19 , that was also observed in CSE-exposed DLD-1 cells, indicating penetration of CSE-mediated signaling to the colon. The high variability of HSPA6 mRNA levels in the colon of individuals who smoke may be a refl ection of smoking behavior prior to the endoscopy together with genetic factors.
Therapeutically, it is now relevant to identify the compound(s) in smoke that are responsible for inducing HSPA6 expression. Cigarette smoke contains high amounts of acrolein and this compounds is known to induce HSPs 66, 67 . As many compounds in cigarette smoke, acrolein is cytotoxic and therapeutic application seems limited.
Alternatively, compounds that selectively induce protective HSPs, including HSPA6, from other sources, could be tested. In fact, one such compound has already been identifi ed, e.g. geranyl-geranyl acetone (GGA). GGA induces HSP70, but its eff ect on HSPA6 is unknown 68 . GGA is an anti-ulcer drug and shows promising antiinfl ammatory eff ects in animal models of colitis 65, [69] [70] [71] [72] . It remains to be determined whether GGA, or derivatives, may alleviate UC and/or CD.
Taken together, we show that HSPA6 is a cigarette smoke-induced gene that resides in a UC susceptibility locus. HSPA6 is prominently expressed in the human colonic epithelium and associates with anti-apoptotic Bcl-XL. HSPA6 may thus be an eff ector protein of the protective eff ect of smoking in UC. Supplementary Table S1 . Primers and probes used in this study.
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